Patent · US Active

Modifications for antisense compounds

US9506059B2 · kind B2 · utility

0Cited by
91References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 26, 2014
Grant dateNov 29, 2016
Priority date
Expiry dateSep 26, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention pertains to modifications for antisense oligonucleotides, wherein the modifications are used to improve stability and provide protection from nuclease degradation. The modifications could also be incorporated into double-stranded nucleic acids, such as synthetic siRNAs and miRNAs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.